Impact of porous microsponges in minimizing myotoxic side effects of simvastatin.

Ahmed U Ali, Mahmoud Abd-Elkareem, Amira A Kamel, Nasser S Abou Khalil, D Hamad, Nasr Eldin Hussein Nasr, Maha A Hassan, Tahani H El Faham

Scientific reports 2023 Apr 08

filter terms:

Simvastatin (SV) is a poorly soluble drug; its oral administration is associated with a significant problem: Myopathy. The present study aims to formulate SV microsponges that have the potential to minimize the myotoxicity accompanying the oral administration of the drug. SV microsponges were prepared by exploiting the emulsion solvent evaporation technique. The % entrapment efficiency (%EE) of the drug approached 82.54 ± 1.27%, the mean particle size of SV microsponges ranged from 53.80 ± 6.35 to 86.03 ± 4.79 µm in diameter, and the % cumulative drug release (%CDR) of SV from microsponges was significantly higher than that from free drug dispersion much more, the specific surface area of the optimized microsponges formulation was found to be 16.6 m2/g revealed the porosity of prepared microsponges. Histological and glycogen histochemical studies in the skeletal muscles of male albino rats revealed that microsponges were safer than free SV in minimizing myotoxicity. These findings were proven by Gene expression of Mitochondrial fusion and fission (Mfn1) & (Fis1) and (Peroxisome proliferator-activated receptor gamma co-activator 1α) PGC-1α. Finally, our study ascertained that SV microsponges significantly decreased the myotoxicity of SV. © 2023. The Author(s).

Citation

Ahmed U Ali, Mahmoud Abd-Elkareem, Amira A Kamel, Nasser S Abou Khalil, D Hamad, Nasr Eldin Hussein Nasr, Maha A Hassan, Tahani H El Faham. Impact of porous microsponges in minimizing myotoxic side effects of simvastatin. Scientific reports. 2023 Apr 08;13(1):5790